These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8142601)
1. Protective effect of natural TNF-binding protein on human TNF-induced toxicity in mice. Ythier A; Gascon MP; Juillard P; Vesin C; Wallach D; Grau GE Cytokine; 1993 Sep; 5(5):459-62. PubMed ID: 8142601 [TBL] [Abstract][Full Text] [Related]
2. Prevention of human TNF-induced cutaneous Shwartzmann reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies. Grau GE; Vesin C; De Groote D; Delacroix D; Gysler C; Piguet PF; Lambert PH Clin Exp Immunol; 1991 Jun; 84(3):411-4. PubMed ID: 2044219 [TBL] [Abstract][Full Text] [Related]
3. Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis. Porat R; Paddock HN; Schwaitzberg SD; Connolly RJ; Wilkens T; Dasch JR; Gascon MP; Hutchison JS; Ythier A; Wallach D Crit Care Med; 1995 Jun; 23(6):1080-9. PubMed ID: 7774220 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicity. Adolf GR; Frühbeis B Cytokine; 1992 May; 4(3):180-4. PubMed ID: 1379835 [TBL] [Abstract][Full Text] [Related]
5. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice. Ameloot P; Takahashi N; Everaerdt B; Hostens J; Eugster HP; Fiers W; Brouckaert P Eur J Immunol; 2002 Oct; 32(10):2759-65. PubMed ID: 12355427 [TBL] [Abstract][Full Text] [Related]
6. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock. Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827 [TBL] [Abstract][Full Text] [Related]
7. Low susceptibility of NC/Nga mice to tumor necrosis factor-alpha-mediated lethality and hepatocellular damage with D-galactosamine sensitization. Koide N; Morikawa A; Naiki Y; Tumurkhuu G; Yoshida T; Ikeda H; Yokochi T Clin Immunol; 2009 Feb; 130(2):225-32. PubMed ID: 18945641 [TBL] [Abstract][Full Text] [Related]
8. Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF. Moos AB; Baecher-Steppan L; Kerkvliet NI Toxicol Appl Pharmacol; 1994 Aug; 127(2):331-5. PubMed ID: 8048078 [TBL] [Abstract][Full Text] [Related]
9. Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions. Norman KE; Williams TJ; Feldmann M; Rossi AG Br J Pharmacol; 1996 Feb; 117(3):471-478. PubMed ID: 8821536 [TBL] [Abstract][Full Text] [Related]
10. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice? Hasunuma R; Maruyama H; Takimoto H; Ryll R; Tanaka S; Kumazawa Y J Endotoxin Res; 2002; 8(5):391-8. PubMed ID: 12537698 [TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids. Adolf GR; Apfler I J Immunol Methods; 1991 Sep; 143(1):127-36. PubMed ID: 1919033 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice. Gascon MP; Porchet HC; Le Cotonnec JY; Ythier A; Wallach D; Piguet PF; Grau GE Drug Metab Dispos; 1992; 20(4):592-5. PubMed ID: 1356740 [TBL] [Abstract][Full Text] [Related]